一种多靶点嵌合抗原受体-T细胞平台,用于克服非小细胞肺癌治疗中抗原异质性问题
A Multi‐Targeting Chimeric Antigen Receptor‐T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non‐Small Cell Lung Cancer
Lina Wang, Yanlei Zhang, Shuixiu Peng, Chenchen Hou, Huaqi Guo, Tianyu Zhou, Alex H Chang, Lifeng Yan, Weining Xiong
Journal:Advanced Science
IF:14.1
DOI:10.1002/advs.77992
PMID:42801642
Published:2026-09-27
research field:肿瘤学分子生物学基因工程肿瘤免疫学免疫治疗细胞治疗
Abstract
Chimeric antigen receptor (CAR)‐T cell therapy for solid tumors is limited by antigen heterogeneity and T cell exhaustion. To address these limitations, we develop a novel multi‐targeting “Bicephali” CAR‐T platform featuring a dual‐transmembrane protein with two distinct extracellular antigen‐binding domains and a shared intracellular 4‐1BB co‐stimulatory/CD3ζ signaling domain. CD276 and NKG2D ligands (NKG2DLs) show high and heterogeneous expression in non‐small cell lung cancer (NSCLC) and are undetectable in normal tissues. Bicephali CAR‐T cells targeting CD276 and NKG2DLs demonstrate superior tumoricidal activity against NSCLC than conventional BB002 CAR‐T cells in vitro and in vivo, together with improved immunological synapse formation and mitochondrial metabolic fitness. In homogeneous NSCLC models co‐expressing CD276 and NKG2DLs, Bicephali CAR‐T cells achieve prolonged survival outcomes compared to monospecific CAR‐T cells. In antigenically heterogeneous NSCLC, Bicephali CAR‐T cells more consistently control tumors and prolong survival, whereas monospecific CAR‐T cells fail to eliminate tumors following antigen loss. Mechanistically, improved mitochondrial fitness and antioxidant capacity in Bicephali CAR‐T cells are associated with sustained T cell function, preserved stem‐like differentiation, and durable effector responses. These findings support a multi‐targeting CAR‐T approach to address antigen heterogeneity in NSCLC and potentially other solid tumors. A dual‐transmembrane Bicephali CAR‐T platform simultaneously targets CD276 and NKG2D ligands to address antigen heterogeneity in non‐small cell lung cancer. By improving immune synapse formation, mitochondrial fitness, antioxidant capacity, and stem‐like persistence, this design enhances durable tumor control and provides a versatile strategy to overcome antigen escape in solid tumors.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


